Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases (Prometheus)
This study has been withdrawn prior to recruitment.
( Boston Scientific has decided to close the Study. )
Study NCT00510627   Information provided by Boston Scientific Corporation
First Received: July 31, 2007   Last Updated: December 20, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Liver Cancer
Secondary Liver Cancer
Liver Neoplasm
Additional conditions recognized in this trial
Colorectal Neoplasms
Liver Neoplasms
Neoplasm Metastasis
Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Liver Diseases
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Rectal Diseases
Interventions listed in this trial
Radiofrequency Ablation (RFA)
Chemotherapy
Additional drug interventions recognized in this trial
Cetuximab
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Boston Scientific Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services